drugset / Trial / NCT04775173

Efficacy and Safety of Different Concentrations of Sirolimus in the Treatment of Kaposiform Hemangioendothelioma.

NCT04775173 ↗

Phase 2 Completed 79 enrolled West China Hospital
RandomizedParallel-groupSingle-blindTreatment

Summary

The purpose of this study is to compare the efficacy and safety of different concentration gradients of sirolimus in the treatment of Kaposiform hemangioendothelioma.

Timeline

Start
2021-02-17
Primary completion
2023-08-10
Completion
2023-08-10

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject Sirolimus Small molecule — —